NBA and GE Healthcare Sports Medicine and Orthopedics Collaboration aimed at prevention, diagnosis and treatment of tendinopathy
In July 2015, the NBA and GE Healthcare teamed up with medical researchers and physicians to help both professional ball players and everyday athletes. The first round of winning research proposals – focused on tendon injuries, specifically in the knee and ankle – is now public. Here’s why it matters.
“Tendinopathy – and specifically that involving the patellar tendon – is a common issue among basketball players at all levels,” said Dr. John DiFiori, the NBA’s Director of Sports Medicine. “The NBA is pleased to work with GE Healthcare to fund additional research in this area to increase our understanding of this condition as we seek to improve health outcomes and limit the impact on athletic performance for NBA players and the general population.”
By combining strong data analytics, expertise in healthcare and a commitment to player health and safety, GE Healthcare and the NBA hope to garner research ideas that help prevent, diagnose and treat commons sports injuries of athletes of all levels across the world. Future calls for research proposals may address bone stress injuries, articular cartilage injury, and other important musculoskeletal issues affecting NBA players.
John M. Sabol, PhD, Chief Scientist for GE Healthcare’s Global Research Organization, noted, “The collaboration between GE Healthcare and the NBA has provided a unique opportunity to do high impact research. This call for proposals attracted dozens of high-quality submissions from leading tendinopathy researchers. Selection of the winning projects was a challenging task, relying on an independent scientific review panel of 22 academic and clinical experts to evaluate the scientific merit of the submitted research projects.”
Read more about the first round winners and their research proposals here.